Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sukhmeet S Panesar is active.

Publication


Featured researches published by Sukhmeet S Panesar.


Allergy | 2014

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy

Antonella Muraro; Thomas Werfel; Karin Hoffmann-Sommergruber; Graham Roberts; Kirsten Beyer; Carsten Bindslev-Jensen; Victoria Cardona; Anthony Dubois; G. duToit; Philippe Eigenmann; M. Fernandez Rivas; Susanne Halken; L. Hickstein; Arne Høst; Edward F. Knol; Gideon Lack; M.J. Marchisotto; Bodo Niggemann; Bright I. Nwaru; Nikolaos G. Papadopoulos; Lars K. Poulsen; Alexandra F. Santos; Isabel Skypala; A. Schoepfer; R. van Ree; Carina Venter; Margitta Worm; B. J. Vlieg-Boerstra; Sukhmeet S Panesar; D. de Silva

Food allergy can result in considerable morbidity, impact negatively on quality of life, and prove costly in terms of medical care. These guidelines have been prepared by the European Academy of Allergy and Clinical Immunologys (EAACI) Guidelines for Food Allergy and Anaphylaxis Group, building on previous EAACI position papers on adverse reaction to foods and three recent systematic reviews on the epidemiology, diagnosis, and management of food allergy, and provide evidence‐based recommendations for the diagnosis and management of food allergy. While the primary audience is allergists, this document is relevant for all other healthcare professionals, including primary care physicians, and pediatric and adult specialists, dieticians, pharmacists and paramedics. Our current understanding of the manifestations of food allergy, the role of diagnostic tests, and the effective management of patients of all ages with food allergy is presented. The acute management of non‐life‐threatening reactions is covered in these guidelines, but for guidance on the emergency management of anaphylaxis, readers are referred to the related EAACI Anaphylaxis Guidelines.


Allergy | 2014

Prevalence of common food allergies in Europe: a systematic review and meta‐analysis

Bright I. Nwaru; L. Hickstein; Sukhmeet S Panesar; Graham Roberts; Antonella Muraro; Aziz Sheikh

Allergy to cows milk, egg, wheat, soy, peanut, tree nuts, fish, and shellfish constitutes the majority of food allergy reactions, but reliable estimates of their prevalence are lacking. This systematic review aimed to provide up‐to‐date estimates of their prevalence in Europe.Studies published in Europe from January 1, 2000, to September 30, 2012, were identified from searches of four electronic databases. Two independent reviewers appraised the studies and extracted the estimates of interest. Data were pooled using random‐effects meta‐analyses. Fifty studies were included in a narrative synthesis and 42 studies in the meta‐analyses. Although there were significant heterogeneity between the studies, the overall pooled estimates for all age groups of self‐reported lifetime prevalence of allergy to cows milk, egg, wheat, soy, peanut, tree nuts, fish, and shellfish were 6.0% (95% confidence interval: 5.7–6.4), 2.5% (2.3–2.7), 3.6% (3.0–4.2), 0.4% (0.3–0.6), 1.3% (1.2–1.5), 2.2% (1.8–2.5), and 1.3% (0.9–1.7), respectively. The prevalence of food‐challenge‐defined allergy to cows milk, egg, wheat, soy, peanut, tree nuts, fish, and shellfish was 0.6% (0.5–0.8), 0.2% (0.2–0.3), 0.1% (0.01–0.2), 0.3% (0.1–0.4), 0.2% (0.2–0.3), 0.5% (0.08–0.8), 0.1% (0.02–0.2), and 0.1% (0.06–0.3), respectively. Allergy to cows milk and egg was more common among younger children, while allergy to peanut, tree nuts, fish, and shellfish was more common among the older ones. There were insufficient data to compare the estimates of soy and wheat allergy between the age groups. Allergy to most foods, except soy and peanut, appeared to be more common in Northern Europe. In summary, the lifetime self‐reported prevalence of allergy to common foods in Europe ranged from 0.1 to 6.0%. The heterogeneity between studies was high, and participation rates varied across studies reaching as low as <20% in some studies. Standardizing the methods of assessment of food allergies and initiating strategies to increase participation will advance this evidence base.


Allergy | 2014

The epidemiology of food allergy in Europe: a systematic review and meta-analysis

Bright I. Nwaru; L. Hickstein; Sukhmeet S Panesar; Antonella Muraro; Thomas Werfel; Victoria Cardona; Anthony Dubois; Susanne Halken; Karin Hoffmann-Sommergruber; Lars K. Poulsen; Graham Roberts; R. van Ree; B. J. Vlieg-Boerstra; Aziz Sheikh

Food allergy (FA) is an important atopic disease although its precise burden is unclear. This systematic review aimed to provide recent, up‐to‐date data on the incidence, prevalence, time trends, and risk and prognostic factors for FA in Europe. We searched four electronic databases, covering studies published from 1 January 2000 to 30 September 2012. Two independent reviewers appraised the studies and qualified the risk of bias using the Critical Appraisal Skills Programme tool. Seventy‐five eligible articles (comprising 56 primary studies) were included in a narrative synthesis, and 30 studies in a random‐effects meta‐analysis. Most of the studies were graded as at moderate risk of bias. The pooled lifetime and point prevalence of self‐reported FA were 17.3% (95% CI: 17.0–17.6) and 5.9% (95% CI: 5.7–6.1), respectively. The point prevalence of sensitization to ≥1 food as assessed by specific IgE was 10.1% (95% CI: 9.4–10.8) and skin prick test 2.7% (95% CI: 2.4–3.0), food challenge positivity 0.9% (95% CI: 0.8–1.1). While the incidence of FA appeared stable over time, there was some evidence that the prevalence may be increasing. There were no consistent risk or prognostic factors for the development or resolution of FA identified, but sex, age, country of residence, familial atopic history, and the presence of other allergic diseases seem to be important. Food allergy is a significant clinical problem in Europe. The evidence base in this area would benefit from additional studies using standardized, rigorous methodology; data are particularly required from Eastern and Southern Europe.


Allergy | 2013

The epidemiology of anaphylaxis in Europe: a systematic review

Sukhmeet S Panesar; Sundas Javad; D. de Silva; Bright I. Nwaru; L. Hickstein; Antonella Muraro; Graham Roberts; Margitta Worm; M.B. Bilò; Victoria Cardona; Anthony Dubois; A. Dunn Galvin; Philippe Eigenmann; Montserrat Fernandez-Rivas; Susanne Halken; Gideon Lack; Bodo Niggemann; Alexandra F. Santos; B. J. Vlieg-Boerstra; Z.Q. Zolkipli; Aziz Sheikh

Anaphylaxis is an acute, potentially fatal, multi‐organ system, allergic reaction caused by the release of chemical mediators from mast cells and basophils. Uncertainty exists around epidemiological measures of incidence and prevalence, risk factors, risk of recurrence, and death due to anaphylaxis. This systematic review aimed to (1) understand and describe the epidemiology of anaphylaxis and (2) describe how these characteristics vary by person, place, and time.


Heart | 2006

Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting—comparison between off-pump and on-pump techniques

Sukhmeet S Panesar; Thanos Athanasiou; Sujit Nair; Christopher Rao; Catherine M. Jones; Mario Nicolaou; Ara Darzi

Objective: To assess early outcomes in the elderly population undergoing coronary revascularisation with and without cardiopulmonary bypass (CPB). Methods: Meta-analysis of all retrospective, non-randomised studies comparing off-pump coronary artery bypass (OPCAB) versus CPB techniques in the elderly (> 70 years) between 1999 and 2005. Age-related early outcomes of interest were death, stroke, atrial fibrillation (AF), renal failure and length of stay in hospital. The random effects model was used. Sensitivity and heterogeneity were analysed. Results: Analysis of 14 non-randomised studies comprising 4921 patients (OPCAB, 1533 (31.1%) and CPB, 3388 (68.9%)) showed a significantly lower incidence of death in the OPCAB group (odds ratio (OR) 0.48, 95% CI 0.28 to 0.84). This effect was greater in OPCAB octogenarians (OR 0.26, 95% CI 0.12 to 0.57). The pattern of incidence of stroke among the OPCAB octogenarians (OR 0.19, 95% CI 0.07 to 0.56) was similar. The incidence of AF was lower in the OPCAB group (OR 0.77, 95% CI 0.61 to 0.97). The incidence of renal failure did not differ. Length of hospital stay was shorter in the OPCAB group, although with significant heterogeneity. Conclusions: OPCAB may be associated with lower incidence of death, stroke and AF in the elderly, which may result in shorter length of hospital stay. A large randomised trial would confirm whether the elderly would benefit more from OPCAB surgery.


Allergy | 2014

The diagnosis of food allergy: a systematic review and meta-analysis

K. Soares-Weiser; Yemisi Takwoingi; Sukhmeet S Panesar; Antonella Muraro; Thomas Werfel; Karin Hoffmann-Sommergruber; Graham Roberts; Susanne Halken; Lars K. Poulsen; R. van Ree; B. J. Vlieg-Boerstra; Aziz Sheikh

We investigated the accuracy of tests used to diagnose food allergy.


Allergy | 2014

Primary prevention of food allergy in children and adults: systematic review.

D. de Silva; M. Geromi; Susanne Halken; Arne Høst; Sukhmeet S Panesar; Antonella Muraro; Thomas Werfel; Karin Hoffmann-Sommergruber; Graham Roberts; Victoria Cardona; Anthony Dubois; Lars K. Poulsen; R. van Ree; B. J. Vlieg-Boerstra; Ioana Agache; Kate Grimshaw; Liam O'Mahony; Carina Venter; Syed Hasan Arshad; Aziz Sheikh

Food allergies can have serious physical, social, and financial consequences. This systematic review examined ways to prevent the development of food allergy in children and adults.


Allergy | 2014

Management of anaphylaxis: a systematic review

Sangeeta Dhami; Sukhmeet S Panesar; Graham Roberts; Antonella Muraro; Margitta Worm; Maria Beatrice Bilò; Victoria Cardona; Anthony Dubois; A. DunnGalvin; Philippe Eigenmann; Montserrat Fernandez-Rivas; Susanne Halken; Gideon Lack; Bodo Niggemann; Franziska Ruëff; Alexandra F. Santos; B. J. Vlieg-Boerstra; Z.Q. Zolkipli; Aziz Sheikh

To establish the effectiveness of interventions for the acute and long‐term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi‐randomized controlled trials, controlled clinical trials, controlled before–after studies and interrupted time series and – only in relation to adrenaline – case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty‐five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1‐antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long‐term management interventions studied were anaphylaxis management plans and allergen‐specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom‐triggered anaphylaxis.


BMJ | 2004

Comparison of reporting of ethnicity in US and European randomised controlled trials

Aziz Sheikh; Gopalakrishnan Netuveli; Joe Kai; Sukhmeet S Panesar

Increasing evidence shows that different ethnic groups respond differently to educational, psychosocial, and pharmacological interventions. If diverse communities are to benefit from the implementation of appropriately derived evidence then it is imperative that the ethnic diversity of populations under study are reflected in clinical trials. In the United States, since 1993, the National Institutes of Health have instituted policy insisting that minority groups are represented in study samples unless there is a compelling reason not to do so.1 However, no comparable legislation exists in Europe. We sought to compare reporting of ethnicity in published reports of US and European randomised controlled studies. We searched Medline for reports of trials published in 2002 using the Cochrane optimal search strategy.2 We downloaded titles and abstracts of study reports into the reference manager database and randomly …


Allergy | 2014

Acute and long-term management of food allergy: systematic review

D. de Silva; M. Geromi; Sukhmeet S Panesar; Antonella Muraro; Thomas Werfel; Karin Hoffmann-Sommergruber; Graham Roberts; Victoria Cardona; Anthony Dubois; Susanne Halken; Arne Høst; Lars K. Poulsen; R. van Ree; B. J. Vlieg-Boerstra; Ioana Agache; Aziz Sheikh

Allergic reactions to food can have serious consequences. This systematic review summarizes evidence about the immediate management of reactions and longer‐term approaches to minimize adverse impacts.

Collaboration


Dive into the Sukhmeet S Panesar's collaboration.

Top Co-Authors

Avatar

Aziz Sheikh

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ara Darzi

Imperial College London

View shared research outputs
Top Co-Authors

Avatar

Saqeb B Mirza

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anthony Dubois

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge